Kynam Capital Management, LP - 31 Mar 2025 SCHEDULE 13G Report for Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN)

Filing Manager: Kynam Capital Management, LP
Reporting Manager: Kynam Capital Management, LP
Security: Viridian Therapeutics, Inc. Common Stock, $0.01 par value
Symbol: VRDN
Disclosed Ownership: 0 shares
Ownership: 5.8%
Form type: SCHEDULE 13G
Filing time: 15 May 2025, 11:44:42 UTC
Date of event: 31 Mar 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Kynam Capital Management, LP	5.8%	0	0	4,700,000	Yue Tang	Managing Member
Kynam Capital Management GP, LLC	5.8%	0	0	4,700,000	Yue Tang	Managing Member
Yue Tang	5.8%	0	0	4,700,000	Yue Tang	Self